Akari Therapeutics PLC(AKTX)
盘后13.25-5.02-27.48%19:59 EDT
18.27+13.13+255.45%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Akari Therapeutics PLC所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Akari Therapeutics, Plc于2004年10月7日在英格兰和威尔士注册成立。该公司是一家临床阶段的生物技术公司，专注于开发涉及补体成分5（“C5”）和白三烯B4（“LTB4”）通路的自身免疫和炎症性疾病的先进疗法。这些途径中的每一种都在疾病靶向中具有科学上得到充分支持的致病作用。该公司认为，阻断炎症的早期介质将防止引发某些疾病的过程的启动和持续放大。公司自成立以来的活动包括进行研发活动和筹集资金。- 05-22 12:00Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-19Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05-08Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 03-30Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 03-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 03-03Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-28Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 01-23Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-12-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-08Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-02Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-11-26Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-17Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-11-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
18.99
今开
9.92
量比
26.88
最低
8.58
昨收
5.14
换手率
3943.50%